Christophe Berthoux, D.V.M.

Christophe Berthoux, DVM, is the executive chair of the board at Aetion. Dr. Berthoux is the former CEO of NAMSA, a contract research organization (CRO), and brings a career of global healthcare leadership experience in both the United States and Europe spanning more than 25 years.

Prior to NAMSA, he served as board member and CEO, Europe at Citoxlab in Paris, a CRO for non-clinical research. For the eight years prior, he held the position of CEO at Synexus Clinical Research Ltd, a multinational, clinical site management organization (SMO) based in London, where he was responsible for overhauling the company’s management structure and business growth strategies.

During a 20 year tenure at Charles River Laboratories, Dr. Berthoux held various positions in the U.S. and Europe, including executive vice president of sales and marketing and chief commercial officer. Berthoux received his Master of Business Administration from Purdue University Daniels School of Business in Indiana after completing his Doctor of Veterinary Medicine degree at the Ecole nationale vétérinaire de Lyon in France.